- Research works
- 47 ▼ 99% vs 2013–17
- Citations
- 2.4k 51.8 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 20% world 28%
Not ranked overall: Celator Pharmaceuticals (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Celator Pharmaceuticals (Canada)?
By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Tumor Targeting, Cancer Therapy, Biomedical Applications, Drug Delivery, Nanocarriers, Surface Engineering and Prognostic Factors.
- ATP-dependent Transporters
- Targeted Therapy
- Fluorescence Imaging
- Reactive Oxygen Species
- Taxanes
- Membrane Lipids
- Chemotherapy-Induced Peripheral Neuropathy
- Childhood Cancer
- Topoisomerases
- aptamers
- DNA nanotechnology
- AML
- Biosensors
- Self-Assembly
- siRNA Delivery
- Chemotherapy
- Prognostic Factors
- Nanocarriers
- Biomedical Applications
- Tumor Targeting
- Nanoparticles
- Cancer Therapy
- Drug Delivery
- Surface Engineering
- Gene Therapy
- RNA Interference
- Hematopoietic Stem Cells
- Genomic Stability
- Immunotherapy
- Acute Myeloid Leukemia
- Membrane Proteins
- DNA
- Acute Lymphoblastic Leukemia
- Ion Channels
- Lipid Rafts
- Photodynamic Therapy
- Calcium Channels
- Voltage-Gated Channels
- Photothermal Therapy
- Therapeutic Targets
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Nanoparticles14▲ 23×7 topics
- Tumor Targeting11▲ 171×3 topics
- Cancer Therapy10▲ 35×4 topics
- Biomedical Applications10▲ 20×4 topics
- Drug Delivery10▲ 43×2 topics
- Nanocarriers9▲ 453×1 topic
- Surface Engineering9▲ 173×1 topic
- Prognostic Factors6▲ 28×4 topics
- Gene Therapy4▲ 31×3 topics
- Chemotherapy4▲ 10×4 topics
- RNA Interference3▲ 65×1 topic
- siRNA Delivery3▲ 96×1 topic
- Hematopoietic Stem Cells3▲ 62×2 topics
- Self-Assembly3▲ 16×4 topics
- Genomic Stability3▲ 64×2 topics
- Biosensors3▲ 10×2 topics
- Immunotherapy3▲ 8.8×5 topics
- AML3▲ 117×1 topic
- Acute Myeloid Leukemia3▲ 117×1 topic
- DNA nanotechnology3▲ 55×1 topic
- Membrane Proteins3▲ 30×2 topics
- aptamers3▲ 55×1 topic
- DNA2▲ 160×1 topic
- Topoisomerases2▲ 160×1 topic
- Acute Lymphoblastic Leukemia2▲ 121×1 topic
- Childhood Cancer2▲ 121×1 topic
- Ion Channels2▲ 14×3 topics
- Chemotherapy-Induced Peripheral Neuropathy1▲ 58×1 topic
- Lipid Rafts1▲ 41×1 topic
- Membrane Lipids1▲ 49×1 topic
- Photodynamic Therapy1▲ 19×2 topics
- Taxanes1▲ 58×1 topic
- Calcium Channels1▲ 36×1 topic
- Reactive Oxygen Species1▲ 5.7×3 topics
- Voltage-Gated Channels1▲ 36×1 topic
- Fluorescence Imaging1▲ 21×1 topic
- Photothermal Therapy1▲ 28×1 topic
- Targeted Therapy1▲ 11×3 topics
- Therapeutic Targets1▲ 10×2 topics
- ATP-dependent Transporters1▲ 42×1 topic
Which research topics does Celator Pharmaceuticals (Canada) publish most on?
By volume in 2022–2025: Dermatology and Skin Diseases, Economic Growth and Development, Copyright and Intellectual Property and Cybercrime and Law Enforcement Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Dermatology and Skin Diseases Dermatology 0 works
- 2 Economic Growth and Development Information Systems 0 works
- 3 Copyright and Intellectual Property Marketing 0 works
- 4 Cybercrime and Law Enforcement Studies Information Systems 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Celator Pharmaceuticals (Canada)'s research output changed?
Output in 2018–2022 was 99% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Vancouver
- University of British Columbia
- BC Cancer Agency
- BC Children's Hospital
- Vancouver General Hospital
- TRIUMF
- St. Paul's Hospital
- University of British Columbia Hospital
- Women's Health Research Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.